Pharmacology

The CVM’s new program prioritizes application reviews for animal drugs whose finished products and active ingredients are both made domestically.

Professional transitions are inevitable, and the key is understanding how to mitigate risk when navigating these transitions.

The prescription oral solution is authorized for short-term prevention in horses as New World screwworm cases in the US continue to rise.

The strategic plan from the CVM aims to close persistent treatment gaps for underserved animal populations, from sheep and fish to dogs and cats with rare diseases.

Results of a study on a GLP-1 therapy in development were presented during the 2026 ACVIM Forum.

Elanco's TruCan Ultra Lyme-L4 is a combination therapy that aims to protect dogs against increasing health risks.

The investigation showed improved stool consistency and microbiome balance in cats and dogs.

Generic Nitenpyram Tablets become the first generic animal drug authorized under an FDA Emergency Use Authorization to treat New World screwworm myiasis in eligible dogs, cats, puppies, and kittens.

Pimobendan Chewable Tablets were approved by the FDA in 2024 for management of mild, moderate, or severe CHF caused by myxomatous mitral valve disease or dilated cardiomyopathy, as a concurrent therapy.

A list of available treatments for screwworm infestations in cattle, horses, sheep, goats, deer, swine, cats, dogs, exotic, zoo, and wildlife species, as well as guidance for practitioners before using these products.

The supplemental approval expands KetoMed's existing label to include a new species and indication, offering veterinarians a generic alternative to the brand-name Ketofen.

The agency is encouraging sponsors of animal drugs for minor use in minor species (MUMS) who meet the eligibility requirements, or their research partners, to apply.

Jennifer Miller, DVM, talks about pharmacology innovation and new therapies for canine parvovirus and itch relief.

Zoetis' doramectin injection is now indicated for use in dairy cows, horses, sheep, swine, and deer to help mitigate NWS myiasis.

CosACTHen by Dechra is indicated for the evaluation of adrenal function in dogs.

Tirnovetmab (Befrena; Elanco) injection received USDA approval in late 2025.

The European Medicines Agency has recommended Nobivac NXT HCPChFelV for market authorization in the European Union.

Pregabalin chewable tablets target nerve-related pain by reducing the release of neurotransmitters involved in pain signaling within the spinal cord.

New research and treatment methods are finding ways to combat the parasitic Varroa mite to save colonies from collapsing.

The FDA's approval of tasipimidine oral solution (Tessie) marks the first time a single product has received federal clearance for both noise aversion and separation anxiety in dogs.

The oral moxidectin therapy is available over the counter.

After years of off-label use, veterinarians now have the first FDA-approved amlodipine formulation specifically indicated for cats with systemic hypertension.

The virtual sessions will address the Animal Drug User Fee Act and Animal Generic Drug User Fee Act.

The authorization adds to a growing list of treatments cleared under emergency use as federal agencies ramp up efforts to prevent New World screwworm from reestablishing in the United States.

Mixlab and Instinct are collaborating to assist veterinarians with prescription ordering and workflow efficiency.